Measuring Response to Therapy by Near-Infrared Imaging of Tumors Using a Phosphatidylserine-Targeting Antibody Fragment
Imaging tumors and their response to treatment could be a valuable biomarker toward early assessment of therapy in patients with cancer. Phosphatidylserine (PS) is confined to the inner leaflet of the plasma membrane in normal cells but is externalized on tumor vascular endothelial cells (ECs) and t...
Saved in:
| Main Authors: | Jian Gong, Richard Archer, Michael Brown, Seth Fisher, Connie Chang, Matthew Peacock, Christopher Hughes, Bruce Freimark |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2013-06-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.2310/7290.2012.00039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01) -
Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
by: Polona Žigon, et al.
Published: (2015-01-01) -
First-in-Man Evaluation of I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment
by: Richard Laforest PhD, et al.
Published: (2017-10-01) -
The Potential of Antibodies Against the Phosphatidylserine / Prothrombin Complex as a Biomarker in Antiphospholipid Syndrome
by: Piotr Pasek, et al.
Published: (2025-02-01) -
Near-infrared photoimmunotherapy using antiGD2 antibody for neuroblastoma and osteosarcoma
by: Jimei Zhao, et al.
Published: (2025-06-01)